Polarean Imaging PLC Ordinary Shares POLX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- GBX 3.65
- Day Range
- GBX 3.67–3.69
- 52-Week Range
- GBX 3.50–33.00
- Bid/Ask
- GBX 0.00 / GBX 0.00
- Market Cap
- GBX 789.36 Mil
- Volume/Avg
- 205,054 / 884,312
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 27.40
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Polarean Imaging PLC designs and manufactures medical drug-device combination companies operating in the high-resolution medical imaging market. Its only operating segment being the development and commercialization of gas polariser devices and ancillary instruments. Geographically, it derives most of the revenue from the United States of America and also has a presence in Canada and the United Kingdom. The company generates revenue from products and services such as Polarisers, Parts and Upgrades, Service and other revenue. Its product portfolio includes 9820 129Xe Hyperpolarizer, 9800 129Xe Hyperpolarizer, Polarean 3777 129Xe Hyperpolarizer Upgrade Module, Polarean 2881 Polarization Measurement Station, and others.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 28
- Website
- https://www.polarean.com
Comparables
Valuation
|
Metric
|
POLX
|
W7L
|
TAM
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 30.78 | 26.98 |
Price/Book Value | 1.39 | 7.94 | 8.85 |
Price/Sales | 27.40 | 4.10 | 11.03 |
Price/Cash Flow | — | 20.60 | 26.12 |
Price/Earnings
POLX
W7L
TAM
Financial Strength
|
Metric
|
POLX
|
W7L
|
TAM
|
|---|---|---|---|
Quick Ratio | 4.66 | 1.56 | 3.62 |
Current Ratio | 5.50 | 3.52 | 3.62 |
Interest Coverage | −735.93 | 35.31 | 48.92 |
Quick Ratio
POLX
W7L
TAM
Profitability
|
Metric
|
POLX
|
W7L
|
TAM
|
|---|---|---|---|
Return on Assets (Normalized) | −60.05% | 17.40% | 26.72% |
Return on Equity (Normalized) | −94.17% | 25.29% | 34.20% |
Return on Invested Capital (Normalized) | −70.09% | 21.39% | 34.91% |
Return on Assets
POLX
W7L
TAM
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Bqtmrvww | Lmfgwzq | $184.4 Bil | |
SYK
| Stryker Corp | Mdgyrmgy | Mpgq | $125.0 Bil | |
MDT
| Medtronic PLC | Mrzvbxqx | Rlvmpg | $107.4 Bil | |
BSX
| Boston Scientific Corp | Rddxndbnq | Jxxrfz | $106.2 Bil | |
EW
| Edwards Lifesciences Corp | Grhpjltwk | Jkspb | $50.8 Bil | |
DXCM
| DexCom Inc | Znrqzmdrl | Spbwb | $49.9 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Ycfkflvlyt | Yrfx | $24.6 Bil | |
PHG
| Koninklijke Philips NV ADR | Scgxmck | Hcxgq | $24.4 Bil | |
ALGN
| Align Technology Inc | Wfldfbvl | Bhjplsm | $21.4 Bil | |
PODD
| Insulet Corp | Vrtwjctc | Rltxqv | $11.9 Bil |